JSJorge Luis Salinas

Jorge Luis Salinas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jorge Luis Salinas has a total of 199 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ralstonia pickettii outbreak in pediatric intensive care units, Peru—2025

    by Medalit Luna-Vilchez, Mitsi Lorraine Santiago Abal, Humania Aguirre Chávez, Claudia Cristel Marroquín Gálvez, Rosario Inés Huasapoma Ortega, Pool Flores Choque, Jorge Osada, Diana Flores-León, Ronnie G. Gavilan, Lizbeth Vanessa Lozano Lozano, et al.

    Objective: Ralstonia spp. are opportunistic gram-negative bacilli that persist in aqueous environments and may cause nosocomial outbreaks. We describe an outbreak of bloodstream infections by Ralstonia pickettii associated with contaminated dexmedetomidine. Methods: Outbreak investigation, including a case–control study, was conducted in a tertiary pediatric hospital (July 19–August 23, 2025), affecting the Cardiovascular, Pediatric, and Burn Intensive Care Units. Species identification was performed using MALDI-TOF MS. Whole-genome sequencing evaluated clonality and phylogenetic relationships with previously reported outbreaks. Environmental sampling and traceability of medical products identified the outbreak source. Results: Eleven R. pickettii bloodstream infections were identified, with 72.73% occurring in the Cardiovascular ICU. The median patient age was 6 months (IQR: 2 mo–7 yr), and fever was the predominant symptom (72.73%). The attack rate was 29.73%, and the case fatality rate was 27.27%. Significant risk factors included exposure to the implicated dexmedetomidine batch (OR 18.75, 95% CI 2.02–173.00, P = .01) and higher dispensed quantity of dexmedetomidine (OR 1.33, 95% CI 1.07–1.67, P = .01). Genomic analysis confirmed clonal R. pickettii (rST-37,889) with close phylogenetic relatedness to outbreaks in Germany and Australia in 2023. All isolates harbored blaOXA-60, blaOXA-22, adeF, and vanH resistance genes. Identical R. pickettii was isolated from the implicated imported dexmedetomidine batch. The outbreak was controlled following withdrawal of the contaminated batch. Conclusions: This first reported outbreak of R. pickettii bloodstream infections linked to intrinsically contaminated dexmedetomidine highlights risks from manufacturing failures in global pharmaceutical supply chains and emphasizes the essential role of genomic surveillance in outbreak investigation.


  • Open Access

    Impact of stopping contact precautions on vanA plasmid transmission, Northern California, 2021–2023

    by Guillermo Rodriguez-Nava, Matthew P. Grieshop, Alessandro Zulli, Aaron A. Behr, Eugenia Miranti, Wajeeha Tariq, Erika Paola Viana-Cardenas, Nathan Pincus, Niaz Banaei, Mindy Sampson, et al.

    Objective: To evaluate the impact of discontinuing contact precautions for vancomycin-resistant enterococci (VRE) on strain and plasmid transmission using long-read whole-genome sequencing (WGS). Study design: Before-after trial of adults with Enterococcus bloodstream infections pre-(Jan–Oct 2021) and post-(Oct–Dec 2021 and Jan–Oct 2023) discontinuation of contact precautions for VRE infections. Setting: Quaternary referral and transplant academic medical center. Patients: Hospitalized adults (≥18 yr) with E. faecalis or E. faecium bacteremia. Methods: Classical epidemiology identified potential transmissions via shared unit exposure within a 14-day window. Blood culture isolates underwent long-read WGS to assess strain and vanA plasmid relatedness. Clonal transmission was defined as P = .679). Genomic analysis identified four clonal transmission events, two of which occurred postdiscontinuation. Among 70 vanA plasmids from 54 patients, 38 highly related plasmids formed a low-diversity cluster. The proportion of cluster plasmids was not significantly different between periods (47% vs 60%; P = .267). Postdiscontinuation, vanA -positive E. faecium ST117 was more prevalent (22/44 vs 53/75; P = .024). Conclusion: Discontinuation of contact precautions for VRE was not associated with increased transmission of enterococci or vanA plasmids in bloodstream infections. Transmission patterns remained largely stable, though the postdiscontinuation period showed increased prevalence of the dominant E. faecium ST117. These findings suggest limited impact of contact precautions on VRE transmission.


  • Open Access

    Use of a large language model integrated within the electronic medical record for the evaluation of surgical site infections – Northern California, 2025

    by Eugenia Miranti, Timothy Keyes, Alvaro Ayala, Nerissa Ambers, Gina Newman, Elmer de Leon, Erika Paola Viana-Cardenas, Wajeeha Tariq, Mindy Sampson, Jorge L. Salinas

    Our study evaluated a large language model (gpt-4o-mini) for surgical site infection (SSI) adjudication, achieving 100% sensitivity but 69.4% specificity. While reducing the manual screening workload by 66%, the agent generated many false positives, underscoring the need for refined models to improve specificity without compromising accuracy.


  • Using Generative Artificial Intelligence for Healthcare-Associated Infection Surveillance

    by Daniel J Morgan, Katherine E Goodman, Westyn Branch-Elliman, Erica S Shenoy, Jorge L Salinas, Makoto Jones, Sunny P Singh, Gregory M Schrank, Lisa Pineles, Shatha AlShanqeeti, et al.

    Generative artificial intelligence (GenAI) is becoming widespread in society but has had limited impact on medicine. GenAI can rapidly digest large documents, making it particularly well suited for healthcare-associated infection (HAI) surveillance that is largely based on clinical notes. In this article, we review evidence on the application of GenAI for HAI surveillance and highlight the necessary steps for changes to practice. Small studies of simulated patients and retrospective studies of patient records have found GenAI can isolate individual criteria for HAI and make HAI determinations with accuracy similar to that of human experts. GenAI tools are being developed to assist in HAI detection. Use of GenAI for HAI review could reduce variability between facilities, improve efficiency of HAI review. and lead to more time for direct prevention work. For widespread adoption, GenAI HAI detection must be safe and effective in prospective clinical studies.


  • Open Access

    Using secure artificial intelligence agents integrated within the electronic medical record for the evaluation of blood culture appropriateness—Northern California, 2025

    by Guillermo Rodriguez-Nava, Timothy Keyes, Nerissa Ambers, Eugenia Miranti, Erika Paola Viana-Cardenas, Wajeeha Tariq, Mindy Marie Sampson, Jorge Luis Salinas

    We evaluated large language model (LLM)-based agents integrated with the electronic medical record to assess blood culture appropriateness. While sensitivity was high, specificity remained low. Performance was shaped by prompt phrasing, sycophantic behavior, and semantic triggers, reflecting both the potential and limitations of LLMs in real-world clinical decision support.


  • Open Access

    Low diagnostic yield of repeat urine cultures in hospitalized patients at a tertiary center in Northern California, 2023–2024

    by Eugenia Miranti, Mindy M. Sampson, John Shepard, Guillermo Rodriguez-Nava, Karen McIntyre, Erika Paola Viana Cardenas, Barbara W. Trautner, Jorge L. Salinas

    We analyzed the diagnostic yield of repeat urine cultures in a retrospective study of adult inpatients. Most urine cultures repeated at less than 6 days provided redundant information. This was true whether the index culture was positive or negative, and whether the threshold for positivity was 10,000 or 100,000 CFU/mL.


  • Open Access

    Performance of a large language model for identifying central line-associated bloodstream infections (CLABSI) using real clinical notes

    by Guillermo Rodriguez-Nava, Goar Egoryan, Katherine E. Goodman, Daniel J. Morgan, Jorge L. Salinas

    We evaluated one of the first secure large language models approved for protected health information, for identifying central line-associated bloodstream infections (CLABSIs) using real clinical notes. Despite no pretraining, the model demonstrated rapid assessment and high sensitivity for CLABSI identification. Performance would improve with access to more patient data.


  • Open Access

    Case Report: Neurobrucellosis Presenting as Malignancy

    by Andrea S. Salcedo, Xosse Carreras, Takaaki Kobayashi, Jorge L. Salinas, Sara Muñoz, Nelson Diaz, Jorge Alave

    : Neurobrucellosis, caused by Brucella species, is a zoonotic infection that may involve the central nervous system. Although uncommon, it can manifest as a solitary intracranial mass. We report a case of neurobrucellosis in a 25-year-old woman from Peru who presented with headache, weight loss, and right-side hemiparesis and paresthesia. A contrast-enhanced magnetic resonance imaging scan revealed an intracerebral mass in the left temporal lobe. Serum testing subsequently were positive. Brain biopsy demonstrated non-necrotizing granulomas without malignant cells. Neurobrucellosis should be considered in the differential diagnosis of brain space occupying lesions in endemic countries.


  • Open Access

    The Obsolescence of Azithromycin for Syphilis Treatment and the Value of Contrasting Different Types of Evidence

    by Gustavo Yano Callado, Jorge L Salinas, Alexandre R Marra

    We appreciate the comments by Cannon et al regarding our article that compared nonpenicillin antibiotics with benzathine penicillin for syphilis treatment. We conducted a systematic literature review and meta-analysis following rigorous scientific and methodological practices, adhering to standardized guidelines as described in our article [ 1]. We aimed to summarize the current knowledge through the highest level of medical evidence, such as randomized controlled trials. Although the meta-analysis suggests a potential role for nonpenicillin regimens, we emphasized that we fully agree with the guidelines of the Centers for Disease Control and Prevention recommending penicillin as the first-line option for treating syphilis at any stage [ 2]. The search for alternative treatments for syphilis seeks to address situations where penicillin cannot be used, such as when there is a shortage of the antibiotic or when the patient is allergic.


  • Insights Into Treatment Alternatives for Neurosyphilis: Systematic Literature Review and Meta-Analysis

    by Gustavo Yano Callado, Isabele Pardo, Maria Celidonio Gutfreund, Rodrigo Octávio Deliberato, Marisa Holubar, Jorge L. Salinas, Christina M. Marra, Eli N. Perencevich, Alexandre R. Marra

    We conducted a systematic literature review and meta-analysis to assess the efficacy of alternative treatments for neurosyphilis. We searched MEDLINE, Cumulative Index to Nursing and Allied Health Literature, Embase, Cochrane, Scopus, and Web of Science from database inception to September 2023, for studies in neurosyphilis that compared penicillin monotherapy with other treatments. We focused on the impact of these therapies on treatment response, but also assessed data regarding reinfection and adverse drug events. Random-effect models were used to obtain pooled mean differences. Of 3415 screened studies, 6 met the inclusion criteria for the systematic literature review. Three studies provided quantitative data that allowed for inclusion in the meta-analysis. Our analysis revealed that the efficacy of intravenous (IV) ceftriaxone 2 g daily for 10 days (51 patients) did not appear statistically different compared with IV penicillin G 18 to 24 million units daily for 10 days (185 patients) for neurosyphilis (pooled odds ratio, 2.85; 95% confidence interval, 0.41–19.56; I2 = 49%). No statistical difference between ceftriaxone and penicillin was identified in people living with human immunodeficiency virus (HIV) (pooled odds ratio, 4.51; 95% confidence interval, 0.50–40.49; I2 = 34%). We concluded that alternative therapy with IV ceftriaxone appears similar to penicillin, potentially expanding treatment options for neurosyphilis. Other treatment options including doxycycline warrant further study.